Seems the alternative delivery system is old news after all
Biota & GSK release 4/5/2009
"- To further expand production volumes, GSK is in active discussions with several other companies to increase manufacturing capacity of the product. As part of this strategy, GSK is also exploring alternative delivery systems for Relenza, beyond the currently approved Diskhaler device. GSK plans to discuss these alternatives with regulatory authorities shortly with the objective of agreeing a potentially expedited pathway to approval and availability."
Biota 1 Hotcopperites 0
Lol :)
OR
BTA Price at posting:
$1.21 Sentiment: Buy Disclosure: Held